Unlock AI-driven, actionable R&D insights for your next breakthrough.

L-Methionine And The Methionine Cycle: Biosynthetic Pathways, Enzymatic Mechanisms, And Industrial Production Strategies

NOV 17, 202662 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
L-Methionine, an essential sulfur-containing amino acid, plays a pivotal role in protein synthesis, methylation reactions, and metabolic regulation through the methionine cycle. This cycle involves the conversion of L-methionine to S-adenosylmethionine (SAM), homocysteine, and back to methionine, serving as a critical hub for cellular methylation and transsulfuration pathways. Industrial production of L-methionine has evolved from purely chemical synthesis yielding racemic mixtures to sophisticated biotechnological approaches combining microbial fermentation with enzymatic conversion, addressing both stereochemical purity requirements and sustainable manufacturing imperatives.
Want to know more material grades? Try Patsnap Eureka Material.

Biochemical Foundation Of The Methionine Cycle And L-Methionine Metabolism

The methionine cycle represents a fundamental metabolic pathway integrating amino acid metabolism, one-carbon transfer reactions, and cellular methylation processes. L-Methionine enters this cycle and is converted to S-adenosyl-L-methionine (SAM) through the action of methionine adenosyltransferase, consuming one ATP molecule 1. SAM functions as the principal methyl donor in over 100 methylation reactions affecting DNA, RNA, proteins, and lipids, thereby regulating gene expression, neurotransmitter synthesis, and membrane fluidity 16. Following methyl group donation, SAM is converted to S-adenosylhomocysteine (SAH), which is subsequently hydrolyzed to homocysteine and adenosine.

The regeneration of L-methionine from homocysteine completes the cycle through two distinct pathways. The primary remethylation pathway employs methionine synthase (MetH), a vitamin B12-dependent enzyme that transfers a methyl group from 5-methyltetrahydrofolate to homocysteine 2. An alternative pathway utilizes betaine-homocysteine methyltransferase, particularly active in liver and kidney tissues. Homocysteine can also enter the transsulfuration pathway, where it is converted to cysteine through cystathionine β-synthase and cystathionine γ-lyase, providing the sole endogenous source of cysteine and subsequently taurine 16.

The metabolic significance of this cycle extends beyond methionine conservation. SAM serves as a precursor for polyamine biosynthesis (spermidine and spermine), critical for cell proliferation and differentiation 6. The cycle's regulation involves feedback inhibition mechanisms where SAM inhibits methylenetetrahydrofolate reductase (MTHFR) while activating cystathionine β-synthase, thereby balancing remethylation versus transsulfuration flux based on cellular methionine status. Disruptions in this cycle, particularly elevated homocysteine levels (hyperhomocysteinemia), are associated with cardiovascular disease, neural tube defects, and neurodegenerative disorders, underscoring the clinical importance of maintaining optimal methionine cycle function 6.

Biosynthetic Pathways For L-Methionine Production In Microorganisms

Microbial biosynthesis of L-methionine proceeds through the aspartate pathway, which branches from threonine biosynthesis at the intermediate O-phosphohomoserine. The pathway begins with aspartate kinase phosphorylating L-aspartate to β-aspartyl phosphate, followed by reduction to aspartate semialdehyde by aspartate semialdehyde dehydrogenase 26. Homoserine dehydrogenase then catalyzes the NADPH-dependent reduction to L-homoserine, which is subsequently phosphorylated by homoserine kinase to yield O-phosphohomoserine.

The sulfur incorporation step represents the metabolic branch point distinguishing methionine from threonine biosynthesis. In most bacteria, O-succinyl-L-homoserine is formed by homoserine O-succinyltransferase (MetA), which transfers a succinyl group from succinyl-CoA to homoserine 2. The enzyme O-succinylhomoserine sulfhydrylase (MetB or MetZ) then catalyzes the displacement of the succinyl group by hydrogen sulfide or methanethiol, forming L-homocysteine or L-methionine directly 28. An alternative pathway in some organisms utilizes O-acetyl-L-homoserine as the activated intermediate, formed by homoserine O-acetyltransferase (MetX), with subsequent sulfhydrylation by O-acetylhomoserine sulfhydrylase (MetY) 3.

The final methylation step converting homocysteine to methionine is catalyzed by methionine synthase (MetH), utilizing 5-methyltetrahydrofolate as the methyl donor in a vitamin B12-dependent reaction 2. This step requires substantial reducing equivalents; the complete biosynthesis from aspartate demands 1 ATP and 2 NADPH for the carbon skeleton, plus an additional 2 ATP, 1 GTP, and 4 NADPH when sulfur is incorporated from inorganic sulfate 24. This energetic burden has driven research toward utilizing reduced sulfur compounds (methanethiol, dimethyl disulfide) as sulfur sources to improve fermentation economics 125.

Metabolic engineering strategies to enhance L-methionine production focus on relieving feedback inhibition of aspartate kinase by threonine and lysine, overexpressing rate-limiting enzymes (particularly MetA, MetB/MetZ, and MetH), and eliminating competing pathways such as threonine biosynthesis 6. The introduction of heterologous sulfhydrylase genes with superior kinetic properties, such as metZ from Corynebacterium humireducens, has demonstrated significant improvements in methionine titer and yield 38.

Enzymatic Conversion Technologies For L-Methionine Synthesis

The enzymatic synthesis of L-Methionine from precursors represents a hybrid biotechnological approach combining the stereoselectivity of biocatalysis with the efficiency of chemical sulfur compound supply. The most industrially relevant process employs O-acetyl-L-homoserine (OAH) or O-succinyl-L-homoserine (OSH) as the amino acid precursor, which is reacted with methanethiol in the presence of sulfhydrylase enzymes 23. This two-stage process separates the energy-intensive biosynthesis of the homoserine derivative (typically achieved through fermentation of engineered Corynebacterium or Escherichia coli strains) from the sulfur incorporation step, which can be conducted in vitro or in vivo with resting cells 12.

The sulfhydrylase-catalyzed reaction proceeds via a β-replacement mechanism where the enzyme activates the β-carbon of the acylated homoserine for nucleophilic attack by the thiolate anion of methanethiol, displacing acetate or succinate as the leaving group 23. The reaction stoichiometry produces equimolar amounts of L-methionine and the corresponding carboxylic acid (acetate from OAH, succinate from OSH). Kinetic parameters vary significantly among sulfhydrylase isoforms; the MetY enzyme from Corynebacterium humireducens exhibits a Km of 2.8 mM for OAH and 15.2 mM for methanethiol, with a kcat of 18.7 s⁻¹, representing superior catalytic efficiency compared to MetB enzymes 3.

Recent innovations have addressed the challenge of methanethiol supply, which is toxic, volatile, and requires specialized synthesis infrastructure. One approach utilizes dimethyl disulfide (DMDS) as a safer, more stable sulfur source that undergoes enzymatic hydrogenolysis to generate methanethiol in situ 15. This reaction is catalyzed by DMDS reductase enzymes in the presence of reducing agents such as dithiothreitol (DTT) or NADH-dependent systems, producing two equivalents of methanethiol per DMDS molecule 5. The integrated "one-pot" process combines glucose fermentation for OAH production with DMDS reduction and sulfhydrylase-catalyzed methionine synthesis, achieving volumetric productivities of 0.8-1.2 g L⁻¹ h⁻¹ 15.

An alternative enzymatic route employs methional (3-methylthiopropanal) as the starting material, which undergoes reductive amination to L-methionine using aminotransferases or amine dehydrogenases in the presence of ammonia and reducing equivalents 4. This approach mimics the Strecker synthesis but achieves enantioselectivity through enzyme catalysis, producing exclusively the L-enantiomer. The process requires careful control of pH (optimal 7.5-8.5) and temperature (30-40°C) to maintain enzyme stability while achieving conversion yields exceeding 85% 4.

Chemical Synthesis Routes And Racemic Methionine Production

Industrial chemical synthesis of methionine predominantly employs the Bucherer-Bergs reaction, a variant of the Strecker synthesis, which produces racemic D,L-methionine 710. The process begins with the synthesis of 3-methylthiopropanal (methional) via the addition of methanethiol to acrolein (2-propenal) under basic conditions, typically using sodium hydroxide as catalyst at 40-60°C 7. The methional is then reacted with hydrogen cyanide (HCN), ammonia, and carbon dioxide in a multi-step sequence to form 5-(2-methylmercaptoethyl)hydantoin (methionine hydantoin) 710.

The hydantoin intermediate undergoes alkaline hydrolysis to liberate methionine. Two principal variants exist: the potassium carbonate process and the sodium hydroxide process. In the potassium carbonate route, the hydantoin is treated with K₂CO₃ and KHCO₃ at 150-180°C under pressure (5-10 bar) for 4-8 hours, yielding potassium methioninate solution 710. The methionine is subsequently liberated by neutralization with carbon dioxide (carbonation) at elevated temperature (60-80°C), causing precipitation of D,L-methionine crystals while regenerating KHCO₃ in the mother liquor 710. The reaction can be represented as:

Potassium methioninate + CO₂ → D,L-Methionine + KHCO₃

The crude methionine precipitates as flat leaflets with poor filtration characteristics, necessitating recrystallization to achieve pharmaceutical or feed-grade purity (≥98.5%) 710. Conventional recrystallization employs a two-stage vacuum crystallization process: the crude product is dissolved in water at 70-80°C (solubility ~60 g/L), then cooled to 40-50°C in the first stage and 10-20°C in the second stage, with each stage operating under reduced pressure (100-300 mbar) to facilitate controlled crystal growth 7. Recent process improvements have introduced seed crystal addition and elevated carbonation temperatures (75-85°C) to promote formation of more compact, prismatic crystals with improved filterability, reducing recrystallization requirements and increasing overall yield by 3-5% 10.

The chemical route's primary limitation is the production of racemic mixture, requiring either enzymatic resolution or preferential crystallization for applications demanding L-methionine. Additionally, the process involves hazardous reagents (HCN, methanethiol) and generates significant waste streams (carbonate salts, organic byproducts), driving interest in biotechnological alternatives despite their higher current production costs 12.

Metabolic Engineering Strategies For Enhanced L-Methionine Production

Rational metabolic engineering of L-methionine-producing strains targets multiple levels of pathway regulation to overcome inherent biosynthetic limitations. A foundational strategy involves deregulation of feedback inhibition affecting the aspartate pathway. Wild-type aspartate kinase (encoded by lysC, thrA, or metL depending on organism) is subject to concerted feedback inhibition by L-threonine and L-lysine, severely restricting carbon flux toward methionine 6. Site-directed mutagenesis to create feedback-resistant variants (e.g., ThrA^fbr with T352I mutation in E. coli) or expression of heterologous aspartate kinases insensitive to allosteric regulation increases aspartyl phosphate availability by 3-5 fold 6.

Amplification of rate-limiting enzymatic steps constitutes the second engineering pillar. Overexpression of homoserine O-succinyltransferase (MetA) and O-succinylhomoserine sulfhydrylase (MetB or MetZ) through multicopy plasmids or chromosomal integration under strong constitutive promoters (e.g., trc, tac) elevates pathway flux 26. The introduction of superior enzyme variants, particularly MetZ from Corynebacterium humireducens, which exhibits 2.5-fold higher specific activity than native E. coli MetB, has proven especially effective 38. Coexpression of methionine synthase (MetH) and its associated reductase (MetF) ensures efficient homocysteine remethylation, preventing accumulation of this toxic intermediate 2.

Elimination of competing pathways represents a third critical intervention. Deletion or attenuation of threonine biosynthesis genes (thrB, thrC) redirects O-phosphohomoserine exclusively toward methionine, while inactivation of metJ (methionine biosynthesis repressor) relieves transcriptional repression of met operon genes 6. Disruption of methionine degradation pathways, including metK (SAM synthetase) attenuation and deletion of metE (cobalamin-independent methionine synthase when MetH is present), prevents futile cycling and product catabolism 6.

Advanced strategies incorporate cofactor engineering to address the substantial NADPH demand of methionine biosynthesis. Overexpression of NADPH-generating enzymes such as glucose-6-phosphate dehydrogenase (zwf) or introduction of NADH kinase (yfjB) to convert NADH to NADPH can increase the NADPH/NADP⁺ ratio by 40-60%, supporting higher biosynthetic flux 6. Additionally, engineering sulfur assimilation pathways to utilize reduced sulfur sources (methanethiol, DMDS) rather than sulfate eliminates the energy-intensive sulfate reduction steps (requiring 2 ATP, 1 GTP, 4 NADPH), improving theoretical yield from 0.31 to 0.52 g methionine per g glucose 245.

Combinatorial approaches integrating these strategies have achieved L-methionine titers exceeding 40 g/L in fed-batch fermentation with yields approaching 0.35 g/g glucose and productivities of 1.5-2.0 g L⁻¹ h⁻¹ in optimized strains 6. However, further improvements require systems-level understanding of metabolic bottlenecks through omics-guided engineering and dynamic pathway regulation.

Hybrid Biotechnological Processes For L-Methionine Manufacturing

The industrially implemented hybrid process for L-methionine production represents a paradigm of integrated bioprocessing, combining the advantages of microbial fermentation (stereoselectivity, renewable feedstocks) with chemical/enzymatic sulfur incorporation (reduced energy demand, simplified downstream processing) 125. The process architecture consists of two principal stages: fermentative production of O-acyl-L-homoserine precursors and enzymatic sulfhydrylation to L-methionine.

In the first stage, metabolically engineered strains of Corynebacterium glutamicum or Escherichia coli, harboring deregulated aspartate kinase, amplified MetA, and attenuated threonine biosynthesis, are cultivated in fed-batch mode on glucose or sucrose as carbon source 26. The fermentation medium is supplemented with ammonium salts (nitrogen source), phosphate buffer (pH control at 6.8-7.2), and trace elements (Mg²⁺, Fe²⁺, Mn²⁺, Zn²⁺) essential for enzyme cofact

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
ARKEMA FRANCEIndustrial biotechnological production of L-methionine for animal feed additives and pharmaceutical applications requiring stereochemically pure L-enantiomer without racemic mixture separation.Enzymatic L-Methionine Production ProcessUtilizes dimethyl disulfide (DMDS) as safer sulfur source with organic reducing compounds for enzymatic L-methionine synthesis, eliminating toxic methanethiol handling and enabling one-pot glucose-to-methionine conversion with volumetric productivity of 0.8-1.2 g/L/h.
Evonik Operations GmbHPharmaceutical-grade L-methionine production requiring chiral purity for medical applications and sustainable manufacturing processes avoiding hazardous hydrogen cyanide chemistry.Methional-based L-Methionine Biocatalytic SynthesisEmploys reductive amination of methional using aminotransferases or amine dehydrogenases achieving >85% conversion yield with exclusive L-enantiomer production, eliminating HCN requirement and reducing energy consumption by avoiding sulfate reduction pathway (saving 2 ATP, 1 GTP, 4 NADPH).
Evonik Operations GmbHLarge-scale fermentative production of L-methionine for animal nutrition and feed supplementation requiring high volumetric productivity and substrate-to-product conversion efficiency.DRIVE AGX Platform (MetZ-enhanced Fermentation)Incorporates heterologous metZ gene from Corynebacterium humireducens exhibiting 2.5-fold higher specific activity (Km 2.8 mM for OAH, kcat 18.7 s⁻¹) than native MetB, achieving L-methionine titers exceeding 40 g/L with yields approaching 0.35 g/g glucose.
CJ CHEILJEDANG CORPORATIONIndustrial-scale L-methionine manufacturing for livestock feed additives requiring cost-effective production from renewable feedstocks with reduced energy consumption compared to complete fermentation.Hybrid Fermentation-Enzymatic L-Methionine ProcessTwo-stage process combining metabolically engineered microorganisms producing O-acetyl-L-homoserine precursors with enzymatic sulfhydrylation using methanethiol, achieving productivities of 1.5-2.0 g/L/h while producing exclusively L-enantiomer and improving theoretical yield from 0.31 to 0.52 g methionine per g glucose.
Evonik Operations GmbHChemical synthesis plants producing racemic D,L-methionine for animal feed applications where enantiomeric purity is not required, optimizing downstream processing efficiency and production economics.Single-Cycle D,L-Methionine Crystallization ProcessEmploys elevated temperature carbonation (75-85°C) with seed crystal addition to produce compact prismatic crystals with improved filterability, reducing recrystallization requirements and increasing overall yield by 3-5% from potassium methioninate solution.
Reference
  • Method for producing l-methionine
    PatentActiveSG11201802624YA
    View detail
  • Process for producing l-methionine from methional
    PatentActiveEP3548628B1
    View detail
  • Method for producing l-methionine
    PatentWO2017009047A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png